Can’t Stop Buying This Dividend Juggernaut: ABBV Growth
A long-time investor explains why AbbVie’s mix of rapidly growing immunology drugs and a dependable dividend keeps dr...
This overview explains risk parity investing and how allocating risk rather than capital can influence retirement portfolio stability.
26,917 articlesA long-time investor explains why AbbVie’s mix of rapidly growing immunology drugs and a dependable dividend keeps dr...
Micron Technology delivered a blockbuster quarter that lifted the chip sector, but investors are already shifting bet...
NOWPayments and KoinX launch Crypto Tax Educational Assets to help global merchants navigate crypto tax rules as cros...
S&P Global Ratings keeps the U.S. sovereign rating at AA+ with a stable outlook, citing economic resilience despite p...
Take-Two CEO Strauss Zelnick is directing a record-setting $1.5 billion launch budget for GTA VI, a move investors wi...
Wealthy investors are tightening tax planning in 2026, leaning on advisers and new strategies to shield gains and boo...
Lilly is backing Absci with a $40 million investment as Absci advances ABS-201, a next-gen injectable targeting hair ...
Harvest Capital and TPG Credit have closed a $600 million recapitalization line for Metro Development Group, enabling...
Rising US energy costs are prompting a rethink on where to place AI data centers. Gulf-backed capacity powered by oil...
Jim Cramer raised questions about the credibility of June payroll data amid a surge in private capital spending by te...
Think you need luck to close rental deals? Not anymore. This guide shows practical, skill-based steps to speed up buy...
Mining profitability remains under pressure as hashprice tests new lows for 2026. Analysts say the bitcoin miner bott...